Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certification & Accreditation
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Pemphigus and bullous pemphigoid in the United States: a 21-year analysis of patient characteristics, treatment patterns, and comorbidities
By
- AMS
posted
Apr 07, 2021 09:54 AM
0
Recommend
.
0 comments
1 view
Related Content
SkinCeuticals, CeraVe, La Roche-Posay & Melanoma Research Alliance Launch Three-Year Partnership in the United States
- AMS
Added May 04, 2020
Blog Entry
Emerging treatments for bullous pemphigoid
- AMS
Added Jul 02, 2021
Blog Entry
Inpatient burden of hidradenitis suppurativa in the United States: analysis of the 2016 National Inpatient Sample
- AMS
Added Jun 30, 2020
Blog Entry
Exploring determinants of psoriasis patients’ treatment choices: a discrete-choice experiment study in the United States and Germany
- AMS
Added Feb 04, 2021
Blog Entry
Hot Products in 2022
Informa Admin
Added Dec 06, 2022
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic